Bryan Grice

VP of Engineering at Jaguar Gene Therapy

Bryan Grice has extensive work experience in the pharmaceutical industry. Bryan is currently the VP of Engineering at Jaguar Gene Therapy, where they support facilities and engineering activities across the company. In their role, they lead efforts around future engineering strategies, equipment design, and facility development.

Prior to their current position, Bryan worked at Pfizer for 8 years, starting in 2013 as the Sr Director of Manufacturing Operations. In this role, they led all manufacturing operations at the Rocky Mount location, focusing on delivering sterile medicine, safety, compliance, and financial performance. Bryan managed a wide range of delivery devices and sterilization methods in a large and dynamic organization.

Before Pfizer, Bryan worked at Hospira for 10 years. Bryan held various roles, including Lead Director of Remediation, where they led efforts to improve alignment to global regulatory standards at the Rocky Mount location. Bryan also served as the Director of Operations of a large aseptic lyophilization facility, with international exposure to multiple regulatory bodies. Additionally, they held roles as Manufacturing Manager, Engineering Manager, and Aseptic Manufacturing Manager, where they were responsible for various aspects of facility operations and engineering support.

Overall, Bryan Grice has a strong background in pharmaceutical manufacturing operations and facility engineering, with a focus on regulatory compliance and continuous improvement.

Bryan Grice attended NC State from 1986 to 1990, where they obtained a Bachelor of Science degree in Mechanical Engineering.

Location

Rocky Mount, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Jaguar Gene Therapy

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. Led by the former AveXis leadership team and backed by Deerfield Management, a healthcare-specific investment firm, Jaguar brings streamlined R&D, manufacturing and clinical operations to accelerate development and potential approval of therapies for severe genetic diseases.


Industries

Employees

51-200

Links